Dr. Hutton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6501 Fannin St
# NB100
Houston, TX 77030Phone+1 713-798-5975Fax+1 713-798-5864
Education & Training
Baylor College of MedicineResidency, Neurology, 1997 - 2000- Baylor College of MedicineInternship, Internal Medicine, 1996 - 1997
Vanderbilt University School of MedicineClass of 1996
Certifications & Licensure
TX State Medical License 1997 - 2026
LA State Medical License 2020 - 2022- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Start of enrollment: 2006 Jul 01
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 11 citationsEvaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.Robert Yapundich, Angela Applebee, Francois Bethoux, Myla D. Goldman, George J. Hutton
International Journal of MS Care. 2015-06-03 - 28 citationsCurrent Advances in Pediatric Onset Multiple SclerosisKristen Fisher, Fernando X. Cuascut, Victor M. Rivera, George J. Hutton
Biomedicines. 2020-03-28 - 60 citationsResults of the Avonex Combination Trial (ACT) in relapsing-remitting MSJeffrey A. Cohen, Peter B. Imrey, Peter A. Calabresi, Keith R. Edwards, T. Eickenhorst
Neurology. 2009-02-10
Press Mentions
MS Diagnosis: What to Know About Tests and Treatments for Multiple SclerosisNovember 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
